Other TOR1AIP1 mutations manifest as a progeroid-like multisystemic condition (including, but not limited to, progressive neurological deterioration, cardiac/skeletal muscle defects and cataracts) [23,24] or as striated muscle disorders [13,16,[18], [19], [20], [21], [22]]. This evidence concerns the gene TOR1AIP1 and cataract.